治疗慢性不治愈的医疗管理:一个病例系列
Joseph Jose1, Bhanushree Soni2, Saji Jose1
1Cardiovascular Medicine, Cardiff Health Centre, Manarcad, IND.
Cureus
|January 3, 2024
概括
一种新的医疗策略有效地治愈了25名患者的慢性不治愈的腿部 (NHUs) 具有类风湿特征. 这种方法针对炎症,显示出有希望的结果,副作用最小.
科学领域:
- 皮肤病学 皮肤病学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性不愈合的腿部 (NHUs) 被定义为持续超过六周的膝盖以下皮肤缺陷.
- 这些会给患者和医疗保健系统带来重大的身体,情绪和经济负担.
研究的目的:
- 为具有风湿特征的NHUs提出一个创新的医疗战略.
- 评估这一策略在实现完全愈合方面的有效性.
主要方法:
- 实证医学治疗方案被使用,结合了德夫拉扎科特,素,达普松,氧化和阿扎西奥普林.
- 对接受这种治疗的25名患有慢性脚踏的患者进行了回顾性分析.
主要成果:
- 的平均持续时间为7.84年,平均愈合时间为5.97个月.
- 在25名患者中,有19名患者出现了非典型的,有4名患者出现了静脉,有2名患者出现了糖尿病神经病变.
- 四名患有静脉的患者也接受了静脉内激光切除术.
结论:
- 开发的医疗策略在治疗与类风湿病相关的慢性NHU方面显示出有希望的结果.
- 治疗方法耐受良好,没有显示任何显著的类固醇诱导的不良影响.
相关概念视频
01:26Peptic Ulcer Disease IV: Management
95
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
95
01:23Gastritis III: Clinical Manifestations and Management
268
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
268
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
308
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
308
01:29Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
492
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
492
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
444
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
444